Ep. 106 - China's C-suite Hears FDA, Plus AACR, ARPA-H
BioCentury This Week
00:00
Do You Know What's Next?
Fizer and some other companies have caused the clinical trials that they're doing in russia to stop. The us Patent and trade mark fice issued a statement basically cutting off communications with its counterpart in Russia. We did a little leg work for you all breaking down all these bills. You can find that story on our web site, abot a century dot com, complete with a sponsor and summary of each of the bills.
Transcript
Play full episode
